Atlas Trials

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

Clinical trial NCT05385185 · UNKNOWN

Trial details

NCT number
NCT05385185
Sponsor
Hebei Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Leptomeningeal MetastasisImmune Checkpoint InhibitorEndostatin
Start date
2022-05-01
Primary completion
2024-05-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.